9p24.1 Genetic Alteration and PD-L1 Expression Are Characteristic of de Novo and Methotrexate-associated Epstein-Barr Virus-positive Hodgkin Lymphoma, but Not Methotrexate-associated Hodgkin-like Lesions

Sawako Shiraiwa, Yara Yukie Kikuti, Joaquim Carreras, Yusuke Kondo, Ken Ohmachi, Yoshiaki Ogawa, Hiroshi Kawada, Shinji Sato, Yuka Gion, Yasuharu Sato, Naoya Nakamura, Kiyoshi Ando

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of '9p24.1 Genetic Alteration and PD-L1 Expression Are Characteristic of de Novo and Methotrexate-associated Epstein-Barr Virus-positive Hodgkin Lymphoma, but Not Methotrexate-associated Hodgkin-like Lesions'. Together they form a unique fingerprint.

Medicine & Life Sciences